ALMR ALAMAR BIOSCIENCES INC revenue, earnings and financials
For the quarter ended June 30, 2026, ALAMAR BIOSCIENCES INC reported revenue of $29.4M (up 82.1% from a year earlier), net income of −$13.2M and diluted EPS of −$0.22.
ALMR quarterly revenue and earnings
- Quarter ended Jun 30, 2026: revenue $29.4M (up 82.1% year over year), net income −$13.2M, EPS −$0.22
- Quarter ended Mar 31, 2026: revenue $26.0M (up 98.9% year over year), net income −$21.3M, EPS −$1.74
- Quarter ended Jun 30, 2025: revenue $16.2M, net income −$7.02M, EPS −$0.62
- Quarter ended Mar 31, 2025: revenue $13.1M, net income −$7.66M, EPS −$0.68
ALMR balance sheet
- Jun 30, 2026: cash $133M, total assets $391M, total liabilities $78.1M, shareholders' equity $313M
- Mar 31, 2026: cash $64.6M, total assets $186M, total liabilities $130M, shareholders' equity −$178M
- Dec 31, 2025: cash $30.0M, total assets $140M, total liabilities $64.0M, shareholders' equity −$159M